Medlab Clinical Limited

Medlab Clinical Limitedverified

MDC.AX

Price:

$6.6

Market Cap:

$15.07M

Medlab Clinical Limited, a biotechnology company, researches, develops, and pre-commercializes pharmaceutical and nutraceutical products in Australia. Its drug candidate includes NanaBis, a buccal spray from cannabis oil extract for oncology and pain management; and NanoCBD, a buccal spray from hemp oil extract for mental health. The company also develops NanoCelle, a patented sub-micron drug delivery platform that allows passive diffusion of active pharmaceutical ingredients directly into the bloodstream through oral-buccal, sublingual, intranasal, and transdermal or topical delivery. In addition, it offers virtual clinic services. The company was founded in 2012 and is headquartered in Bot...[Read more]

Industry

Biotechnology

IPO Date

2015-07-14

Stock Exchange

ASX

Ticker

MDC.AX

The PE Ratio as of November 2025 (TTM) for Medlab Clinical Limited (MDC.AX) is -0.01

According to Medlab Clinical Limited’s latest financial reports and current stock price. The company's current PE Ratio is -0.01. This represents a change of -99.84% compared to the average of -7.42 of the last 4 quarters.

Medlab Clinical Limited (MDC.AX) Historical PE Ratio (quarterly & annually)

How has MDC.AX PE Ratio performed in the past?

The mean historical PE Ratio of Medlab Clinical Limited over the last ten years is -11.09. The current -0.01 PE Ratio has changed -89.13% with respect to the historical average. Over the past ten years (40 quarters), MDC.AX's PE Ratio was at its highest in in the December 2014 quarter at 0. The PE Ratio was at its lowest in in the June 2024 quarter at -25.06.

Quarterly (TTM)
Annual

Average

-11.09

Median

-5.27

Minimum

-41.17

Maximum

0

Medlab Clinical Limited (MDC.AX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Medlab Clinical Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 218.31%

Maximum Annual PE Ratio = 0

Minimum Annual Increase = -Infinity%

Minimum Annual PE Ratio = -41.17

Quarterly (TTM)
Annual
YearPE RatioChange
2024-7.07218.31%
2023-2.2213.09%
2022-1.96-43.35%
2021-3.4737.35%
2020-2.53-72.06%
2019-9.04-60.73%
2018-23.02-44.10%
2017-41.17101.49%
2016-20.43-Infinity%

Medlab Clinical Limited (MDC.AX) Average PE Ratio

How has MDC.AX PE Ratio performed in the past?

The current PE Ratio of Medlab Clinical Limited (MDC.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-3.75

5-year avg

-3.45

10-year avg

-11.09

Medlab Clinical Limited (MDC.AX) PE Ratio vs. Peers

How is MDC.AX’s PE Ratio compared to its peers?

Medlab Clinical Limited’s PE Ratio is greater than Bionomics Limited (-0.03), greater than Incannex Healthcare Limited (-0.26), greater than Kazia Therapeutics Limited (-0.88), greater than Asian American Medical Group Limited (-17.47), greater than 1st Group Limited (-3.95), greater than AusCann Group Holdings Ltd (-1.63), greater than MGC Pharmaceuticals Limited (-0.06), greater than Rhinomed Limited (-1.05), greater than Living Cell Technologies Limited (-11.55), greater than CardieX Limited (-1.12),

Build a custom stock screener for Medlab Clinical Limited (MDC.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medlab Clinical Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Medlab Clinical Limited (MDC.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Medlab Clinical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Medlab Clinical Limited's PE Ratio?

How is the PE Ratio calculated for Medlab Clinical Limited (MDC.AX)?

What is the highest PE Ratio for Medlab Clinical Limited (MDC.AX)?

What is the 3-year average PE Ratio for Medlab Clinical Limited (MDC.AX)?

What is the 5-year average PE Ratio for Medlab Clinical Limited (MDC.AX)?

How does the current PE Ratio for Medlab Clinical Limited (MDC.AX) compare to its historical average?